Related Experiment Video
Updated: Jun 27, 2026

Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
Glycolysis: The Bridge Between Cellular Interaction and Alzheimer's Disease
Qian Lei1, Yinghan He1, Bo Fang1
1Department of Anesthesiology, The First Hospital of China Medical University, NO. 155, North Nanjing Street, Heping District, Shenyang 110001, China.
Alzheimer's disease (AD) involves abnormal brain cell communication and energy metabolism. Targeting glycolysis, a key metabolic pathway, may offer new therapeutic strategies by modulating these cell interactions.
Area of Science:
- Neuroscience
- Metabolic pathways
- Cellular biology
Background:
- Alzheimer's disease (AD) pathology involves neuronal damage and disrupted neuroimmune communication.
- Aberrant glycolysis, a core metabolic pathway, is implicated in AD progression.
- Altered cellular interactions in the brain microenvironment are critical in AD.
Purpose of the Study:
- To systematically review cell interactions in AD, including microglia, astrocytes, oligodendrocytes, and neurons.
- To elucidate the role of glycolysis in regulating cell-cell interactions during AD progression.
- To explore potential therapeutic strategies targeting glycolysis for AD treatment.
Main Methods:
- Systematic review of cellular interactions in AD.
- Analysis of altered glycolytic profiles in AD neuronal cell types.
- Integration of current research on glycolytic pathway control and therapeutic approaches.
Main Results:
- Key changes in cell interactions (microglia, astrocytes, oligodendrocytes, neurons) contribute to neuroinflammation, synaptic loss, and amyloid deposition in AD.
- Glycolysis alterations influence neuronal signaling, inflammatory responses, and cellular functions, impacting cell-cell interactions.
- Dysregulated glycolysis acts as a mediator in altered cell-cell interactions throughout AD progression.
Conclusions:
- Glycolysis plays a crucial role in regulating cell-cell interactions within the neuroimmune microenvironment in AD.
- Modulating glycolysis offers a potential therapeutic avenue for AD by targeting intercellular communication.
- Metabolic reprogramming focused on glycolysis may provide a basis for novel disease-modifying therapies for Alzheimer's disease.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
What is Glycolysis?
Cells make energy by breaking down macromolecules. Cellular respiration is the biochemical process that converts "food energy" (from the chemical bonds of macromolecules) into chemical energy in the form of adenosine triphosphate (ATP). The first step of this tightly regulated and intricate process is glycolysis. The word glycolysis originates from the Latin glyco (sugar) and lysis (breakdown). Glycolysis serves two main intracellular functions: generating ATP and generating...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Glycolysis
Glycolysis: Preparatory Phase